Cure Starts Now Inc
- Assets
- $4.1m
- Revenue
- $5.1m
- Investments
- $0.0
- Employees
- 20
- Location
- Cincinnati, OH
- Founding
- 09/2007
- Data as of
- 12/2023
- EIN
- 26-0269131
Organization Overview
Cure Starts Now Inc, operating under the name Monkey In My Chair, is located in Cincinnati, OH. The organization was established in 2007. According to its NTEE Classification (G48) the organization is classified as: Brain Disorders, under the broad grouping of Voluntary Health Associations & Medical Disciplines and related organizations. As of 12/2023, Monkey In My Chair employed 20 individuals. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. Monkey In My Chair is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.
For the year ending 12/2023, Monkey In My Chair generated $5.1m in total revenue. This represents relatively stable growth, over the past 9 years the organization has increased revenue by an average of 7.1% each year. All expenses for the organization totaled $4.8m during the year ending 12/2023. You can explore the organizations financials more deeply in the financial statements section below.
Since 2015, Monkey In My Chair has awarded 60 individual grants totaling $10,551,402. If you would like to learn more about the grant giving history of this organization, scroll down to the grant profile section of this page.
Form
990
Mission & Program ActivityExcerpts From the 990 Filing
TAX YEAR
2023
Describe the Organization's Mission:
Part 3 - Line 1
TO EDUCATE, AID, AND FUND CURES FOR CANCER, STARTING FIRST WITH PEDIATRIC BRAIN CANCER
Describe the Organization's Program Activity:
Part 3 - Line 4a
IN ITS EFFORTS TO FOCUS ON THOSE CANCERS THAT PRESENT THE GREATEST OPPORTUNITIES FOR AN ENCOMPASSING CANCER CURE, THE FOUNDATION ANNUALLY AWARDS RESEARCH GRANTS TO INSTITUTIONS AND MEDICAL PROFESSIONALS. TYPICALLY, GRANTS AWARDED HAVE A FOCUS ON PEDIATRIC BRAIN CANCERS, AS THIS WAS THE ORIGIN OF THE FOUNDATION'S PHILOSOPHY. GRANT APPLICATIONS WILL BE JUDGED ON A PEER-REVIEWED BASIS WITH THE FOUNDATION'S MEDICAL ADVISORY COUNCIL, WHICH IS COMPRISED OF TOP ONCOLOGISTS AND RESEARCHERS FROM AROUND THE WORLD, AS WELL AS PARENT ADVOCATES. GRANTS ARE JUDGED BASED ON MULTIPLE CRITERIA INCLUDING SCIENTIFIC MERIT, DISEASE IMPACT, INNOVATION, FEASIBILITY, AND EXPERTISE OF THE INVESTIGATOR.
THE DIPG/DMG SYMPOSIUM, ORIGINALLY HELD IN CINCINNATI IN 2011, IS A BIENNIAL CONFERENCE THAT FEATURES CANCER EXPERTS FROM AROUND THE WORLDIN COLLABORATION WITH FAMILIES AND FOUNDATIONS SUPPORTING THEIR WORK.ATTENDED BY FOUNDATIONS AND INSTITUTIONS WORLDWIDE. THE DIPG/DMGCOLLABORATIVE SYMPOSIUM QUICKLY BECAME A DYNAMIC COOPERATIVE, EXPLORINGREVOLUTIONARY DIPG AND DMG RESEARCH, CLINICAL PROTOCOLS, AND UNIVERSALAPPLICATIONS OF DIPG RESEARCH IN THE SEARCH FOR A CURE FOR ALL FORMS OFCANCER.
FAMILY SUPPORT AND AWARENESS FUNDS PROVIDE EMOTIONAL SUPPORT, MECHANISMS TO HONOR THEIR CHILD'S LEGACY AND OTHER ASSISTANCE FOR FAMILIES BATTLING PEDIATRIC CANCER. THIS INCLUDES INFORMATION WEBSITES, TRIAL DISCOVERY TOOLS, PATIENT ASSISTANCE AND PROGRAMS TO FEATURE PATIENTS WITH THE INTENTION OF BUILDING LOCAL SUPPORT AND AWARENESS.
Get More from Intellispect for FreeCreate a free account to get more data, nonprofit salaries, advanced search and more.
Board, Officers & Key Employees
| Name (title) | Role | Hours | Compensation |
|---|---|---|---|
Keith Desserich Chairman | OfficerTrustee | 60 | $33,166 |
Doug Desserich Director/treasurer | OfficerTrustee | 1 | $0 |
Gavin Baumgardner Director | OfficerTrustee | 5 | $0 |
Tamara Ekis Director | OfficerTrustee | 1 | $0 |
Dan Lee Director | OfficerTrustee | 1 | $0 |
Alyssa Hawranko Director | OfficerTrustee | 1 | $0 |
Financial Statements
| Statement of Revenue | |
|---|---|
| Federated campaigns | $0 |
| Membership dues | $0 |
| Fundraising events | $150,561 |
| Related organizations | $0 |
| Government grants | $0 |
| All other contributions, gifts, grants, and similar amounts not included above | $3,524,402 |
| Noncash contributions included in lines 1a–1f | $0 |
| Total Revenue from Contributions, Gifts, Grants & Similar | $3,674,963 |
| Total Program Service Revenue | $0 |
| Investment income | $0 |
| Tax Exempt Bond Proceeds | $0 |
| Royalties | $0 |
| Net Rental Income | $0 |
| Net Gain/Loss on Asset Sales | $0 |
| Net Income from Fundraising Events | $1,402,855 |
| Net Income from Gaming Activities | $0 |
| Net Income from Sales of Inventory | $0 |
| Miscellaneous Revenue | $0 |
| Total Revenue | $5,080,693 |
| Statement of Expenses | |
|---|---|
| Grants and other assistance to domestic organizations and domestic governments. | $1,194,236 |
| Grants and other assistance to domestic individuals. | $0 |
| Grants and other assistance to Foreign Orgs/Individuals | $1,077,428 |
| Benefits paid to or for members | $0 |
| Compensation of current officers, directors, key employees. | $258,302 |
| Compensation of current officers, directors, key employees. | $8,945 |
| Compensation to disqualified persons | $0 |
| Other salaries and wages | $682,101 |
| Pension plan accruals and contributions | $0 |
| Other employee benefits | $321,737 |
| Payroll taxes | $0 |
| Fees for services: Management | $0 |
| Fees for services: Legal | $6,413 |
| Fees for services: Accounting | $47,456 |
| Fees for services: Lobbying | $0 |
| Fees for services: Fundraising | $0 |
| Fees for services: Investment Management | $0 |
| Fees for services: Other | $11,464 |
| Advertising and promotion | $160,098 |
| Office expenses | $124,006 |
| Information technology | $18,137 |
| Royalties | $0 |
| Occupancy | $189,077 |
| Travel | $45,377 |
| Payments of travel or entertainment expenses for any federal, state, or local public officials | $0 |
| Conferences, conventions, and meetings | $101,006 |
| Interest | $0 |
| Payments to affiliates | $0 |
| Depreciation, depletion, and amortization | $38,547 |
| Insurance | $11,443 |
| All other expenses | $1,436 |
| Total functional expenses | $4,760,307 |
| Balance Sheet | |
|---|---|
| Cash—non-interest-bearing | $3,467,967 |
| Savings and temporary cash investments | $0 |
| Pledges and grants receivable | $1,374 |
| Accounts receivable, net | $0 |
| Loans from Officers, Directors, or Controlling Persons | $0 |
| Loans from Disqualified Persons | $0 |
| Notes and loans receivable | $0 |
| Inventories for sale or use | $0 |
| Prepaid expenses and deferred charges | $236,410 |
| Net Land, buildings, and equipment | $45,123 |
| Investments—publicly traded securities | $2,047 |
| Investments—other securities | $0 |
| Investments—program-related | $0 |
| Intangible assets | $29,940 |
| Other assets | $348,046 |
| Total assets | $4,130,907 |
| Accounts payable and accrued expenses | $100,794 |
| Grants payable | $1,227,428 |
| Deferred revenue | $27,663 |
| Tax-exempt bond liabilities | $0 |
| Escrow or custodial account liability | $0 |
| Loans and other payables to any current Officer, Director, or Controlling Person | $0 |
| Secured mortgages and notes payable | $0 |
| Unsecured mortgages and notes payable | $0 |
| Other liabilities | $348,046 |
| Total liabilities | $1,703,931 |
| Net assets without donor restrictions | $1,923,616 |
| Net assets with donor restrictions | $503,360 |
| Capital stock or trust principal, or current funds | $0 |
| Paid-in or capital surplus, or land, building, or equipment fund | $0 |
| Retained earnings, endowment, accumulated income, or other funds | $0 |
| Total liabilities and net assets/fund balances | $4,130,907 |
Grants Awarded
Over the last fiscal year, Cure Starts Now Inc has awarded $1,025,000 in support to 10 organizations.
| Grant Recipient | Amount |
|---|---|
PEDIATRIC BRAIN TUMOR CONSORTIUM FOUNDATION PURPOSE: MEDICAL RESEARCH | $25,000 |
MEMORIAL SLOAN KETTERING CANCER CENTER PURPOSE: CSF CELL-FREE TUMOR DNA LIQUID BIOPSIES | $100,000 |
CINCINNATI CHILDREN'S HOSPITAL PURPOSE: DR BIPLAB DASGUPTA - EXPLORING NOVEL TARGETS IN DIPG | $50,000 |
UNIVERSITY OF COLORADO DENVER-VENKATARAMA PURPOSE: DR SUJATHA VENKATARAMAN-PRECLINICAL ASSESSMENT EFFICACY & SPECIFICITY | $200,000 |
UNIVERSITY OF CHICAGO MEDICAL CENTER PURPOSE: DR ERIC THOMPSON CHARACTERINZING & TARGETING ABL1 & ABL2 IN MEDULO LEPTOMENINGEAL DESSEMINATION | $100,000 |
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI PURPOSE: DR DOLORES HAMBARDZUMYAN TARGETING MACROPHAGES TO IMPROVE THE SURVIVAL OF DIPG | $100,000 |